• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

University of Washington — Syphilis Vaccine Development (David Baker and Neil King)

Visit Grantee Site
  • Portfolio Area: Human Health and Wellbeing
  • Focus Area: Scientific Research
  • Organization Name: University of Washington
  • Amount: $283,539

  • Award Date: December 2021

Table of Contents

    Open Philanthropy recommended a grant of $283,539 to the University of Washington to support research by David Baker and Neil King aimed at developing a vaccine for syphilis.

    Baker and King are participating in a collaborative project with Kelly Hawley and Melissa Caimano at the University of Connecticut Health Center, Lorenzo Giacani at the University of Washington, and Anastassia Vorobieva at the Flanders Institute for Biotechnology. (See “Related Items”, below.)

    This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

    Related Items

    • Human Health and Wellbeing

      University of Connecticut Health Center — Syphilis Vaccine Development

      Open Philanthropy recommended a grant of $4,563,250 to the University of Connecticut Health Center to support work by Kelly Hawley and Melissa Caimano on the development of a...

      Read more
    • Human Health and Wellbeing

      Flanders Institute of Biotechnology — Syphilis Vaccine Research

      Open Philanthropy awarded €725,300 ($731,828 at the time of conversion) to the Flanders Institute of Biotechnology to support Anastassia Vorobieva's research on the development of a vaccine...

      Read more
    • Human Health and Wellbeing

      University of Washington — Syphilis Vaccine Development (Lorenzo Giacani)

      Grant Investigators: Heather Youngs and Chris Somerville This page was reviewed but not written by the grant investigators. University of Washington staff also reviewed this page prior to publication. Open...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 This work is licensed under a Creative Commons Attribution-Noncommercial-Share-alike 4.0 International License. If you'd like to translate this content into another language, please get in touch!